Atlas Trials

TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes

Clinical trial NCT05462457 · RECRUITING

Trial details

NCT number
NCT05462457
Sponsor
Kliniken Essen-Mitte
Status
RECRUITING
Study type
OBSERVATIONAL
Breast CancerNode-positive Breast Cancer
Start date
2022-03-07
Primary completion
2027-03-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.